HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Products In Brief

This article was originally published in The Rose Sheet

Executive Summary

Wet n wild Launches Lash Enhancers

You may also be interested in...



Markwins' Wet N Wild To Offer Value-Priced Lash-Growth Products In 2011

Markwins' wet n wild brand plans to make a splash in the typically pricey lash-growth market with the introduction of a $6.99 serum at mass retailers in January 2011

EWG Advises Against Vitamin A Compound, More Than 90% Of Sunscreens

In its 2010 sunscreen report, the Environmental Working Group smears the vast majority of products on the market and takes special issue with those containing vitamin A compound retinyl palmitate, which may increase the risk of skin cancer when exposed to sun, the organization says

Out Of Bankruptcy, Crabtree & Evelyn Emphasizes Consumer Relationships

Embracing its "fresh start," Crabtree & Evelyn is focused on positioning its brand and engaging consumers this year as it emerges from bankruptcy in the U.S

UsernamePublicRestriction

Register

RS017404

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel